Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Si-Bone (SIBN) Common Equity (2017 - 2025)

Si-Bone has reported Common Equity over the past 9 years, most recently at $177.5 million for Q4 2025.

  • Quarterly results put Common Equity at $177.5 million for Q4 2025, up 6.33% from a year ago — trailing twelve months through Dec 2025 was $177.5 million (up 6.33% YoY), and the annual figure for FY2025 was $177.5 million, up 6.33%.
  • Common Equity for Q4 2025 was $177.5 million at Si-Bone, up from $172.1 million in the prior quarter.
  • Over the last five years, Common Equity for SIBN hit a ceiling of $177.5 million in Q4 2025 and a floor of $94.0 million in Q1 2023.
  • Median Common Equity over the past 5 years was $164.9 million (2024), compared with a mean of $149.6 million.
  • Biggest five-year swings in Common Equity: fell 28.4% in 2022 and later skyrocketed 76.18% in 2024.
  • Si-Bone's Common Equity stood at $134.4 million in 2021, then decreased by 26.87% to $98.3 million in 2022, then surged by 72.3% to $169.4 million in 2023, then decreased by 1.42% to $167.0 million in 2024, then increased by 6.33% to $177.5 million in 2025.
  • The last three reported values for Common Equity were $177.5 million (Q4 2025), $172.1 million (Q3 2025), and $170.3 million (Q2 2025) per Business Quant data.